PE130699A1 - Imidazoilalquilo sustituido con un anillo heterociclico de cinco, seis o siete miembros que contiene un atomo de nitrogeno - Google Patents

Imidazoilalquilo sustituido con un anillo heterociclico de cinco, seis o siete miembros que contiene un atomo de nitrogeno

Info

Publication number
PE130699A1
PE130699A1 PE1998001072A PE00107298A PE130699A1 PE 130699 A1 PE130699 A1 PE 130699A1 PE 1998001072 A PE1998001072 A PE 1998001072A PE 00107298 A PE00107298 A PE 00107298A PE 130699 A1 PE130699 A1 PE 130699A1
Authority
PE
Peru
Prior art keywords
alkyl
trihalometile
nitrogen atom
ring containing
member hetero
Prior art date
Application number
PE1998001072A
Other languages
English (en)
Inventor
John J Piwinski
Robert G Aslanian
Wayne D Vaccaro
Daniel M Solomon
Stuart B Rosenblum
Ronald L Wolin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE130699A1 publication Critical patent/PE130699A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I, X ES ALQUILO C1-C7, ALQUENO O ALQUILENO C2-C4 OPCIONALMENTE SUSTITUIDOS CON R7; n ES 0-2; m ES 0-4; p ES 0-4; CUANDO m ES 0-4; Y ES -SO2-, -CS-, -CO-, -CONR5-, -CO(CH2)wO-, ENTRE OTROS; w ES 1-4; CUANDO m ES 2-4, Y ES TAMBIEN -COR5-, -O-, -NR5CONR5, -CSNR2, ENTRE OTROS; R5 ES H, ALQUILO O BENCILO; R6 ES ARILO, HETEROARILO, HETEROCICLO DE 3-7 MIEMBROS, ARILO SUSTITUIDO CON 1-3 ALQUILO, HALOGENO, TRIHALOMETILO, CN, OR10, NO2, NR10R11; R10 Y R11 SON H, ALQUILO O TRIHALOMETILO; CUANDO Y ES -SO2-, R6 ES ADEMAS ALQUILO C1-C7, NR10R11; R1 ES H, ALQUILO, TRIHALOMETILO; R7 ES H, ALQUILO, TRIHALOMETILO, CN, NO2, OR10R11. TAMBIEN SE REFIERE A UN COMPUESTO PREFERIDO DE FORMULA Ia, ENTRE OTROS. Y A UNA COMPOSICION QUE COMPRENDE ADEMAS UN ANTAGONISTA DEL RECEPTOR DE HISTAMINA H1 COMO LORATADINA, DESCARBOETOXILORATADINA, FEXOFENADINA, CETIRIZINA. EL COMPUESTO I ES UN ANTAGONISTA DEL RECEPTOR H3 Y PUEDE SER UTIL PARA TRATAR ALERGIA, INFLAMACION, ENFERMEDADES CARDIOVASCULARES, HIPOTENSION, GLAUCOMA, DESORDENES DEL SUENO, ENFERMEDADES DEL TRACTO GASTROINTESTINAL, HIPO E HIPER ACTIVIDAD DEL SISTEMA NERVIOSO CENTRAL, ENFERMEDAD DE ALZHEIMER, ESQUIZOFRENIA, OBESIDAD Y MIGRANA
PE1998001072A 1997-11-07 1998-11-06 Imidazoilalquilo sustituido con un anillo heterociclico de cinco, seis o siete miembros que contiene un atomo de nitrogeno PE130699A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96575497A 1997-11-07 1997-11-07

Publications (1)

Publication Number Publication Date
PE130699A1 true PE130699A1 (es) 1999-12-16

Family

ID=25510440

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998001072A PE130699A1 (es) 1997-11-07 1998-11-06 Imidazoilalquilo sustituido con un anillo heterociclico de cinco, seis o siete miembros que contiene un atomo de nitrogeno

Country Status (12)

Country Link
EP (1) EP1028956A1 (es)
JP (1) JP2001522845A (es)
KR (1) KR20010031839A (es)
CN (1) CN1285828A (es)
AR (1) AR016671A1 (es)
AU (1) AU1296799A (es)
CA (1) CA2309609A1 (es)
HU (1) HUP0102662A3 (es)
IL (1) IL135727A0 (es)
PE (1) PE130699A1 (es)
WO (1) WO1999024421A1 (es)
ZA (1) ZA9810186B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140337A (en) * 1997-12-23 2000-10-31 Schering Corporation Methods for the treatment of mental disorders
FR2827863A1 (fr) * 2001-07-27 2003-01-31 Sanofi Synthelabo Derives d'aminoalkylimidazole, leur preparation et leur utilisation en therapeutique
US7183305B2 (en) 2003-11-11 2007-02-27 Allergan, Inc. Process for the synthesis of imidazoles
US7880017B2 (en) 2003-11-11 2011-02-01 Allergan, Inc. Process for the synthesis of imidazoles
EP1695961A4 (en) * 2003-12-17 2007-10-24 Takeda Pharmaceutical UREA DERIVATIVE, METHOD FOR THE PRODUCTION AND THEIR USE
SI1836179T1 (sl) * 2004-12-30 2015-07-31 Janssen Pharmaceutica N.V. Amidni derivati piperidin- in piperazin-1-karboksilne kisline in sorodne spojine kot modulatorji maščobnokislinske amidne hidrolaze (faah) za zdravljenje tesnobe, bolečine in drugih stanj
UA108233C2 (uk) 2010-05-03 2015-04-10 Модулятори активності гідролази амідів жирних кислот
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
WO2022175384A1 (en) * 2021-02-17 2022-08-25 Fundación Universidad Católica De Valencia San Vicente Mártir Small-molecule agents with antiviral activity against rna viruses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993012107A1 (en) * 1991-12-18 1993-06-24 Schering Corporation Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
AU671092B2 (en) * 1991-12-18 1996-08-15 Schering Corporation Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
AU7823894A (en) * 1993-08-27 1995-03-21 Vrije Universiteit New imidazole derivatives having agonistic or antagonistic activity on the histamine h3 receptor
AR008293A1 (es) * 1996-08-16 1999-12-29 Schering Corp Composicion que comprende una cantidad antihistaminica para el tratamiento de las respuestas alergicas de las vias respiratorias superiores

Also Published As

Publication number Publication date
WO1999024421A1 (en) 1999-05-20
HUP0102662A2 (hu) 2001-12-28
CA2309609A1 (en) 1999-05-20
HUP0102662A3 (en) 2003-01-28
AU1296799A (en) 1999-05-31
WO1999024421A8 (en) 1999-08-26
AR016671A1 (es) 2001-07-25
JP2001522845A (ja) 2001-11-20
KR20010031839A (ko) 2001-04-16
CN1285828A (zh) 2001-02-28
ZA9810186B (en) 1999-05-06
EP1028956A1 (en) 2000-08-23
IL135727A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
PE20030417A1 (es) Derivados de urea como antagonistas del receptor vainilloide
CO5280079A1 (es) Nuevos compuestos
PE130699A1 (es) Imidazoilalquilo sustituido con un anillo heterociclico de cinco, seis o siete miembros que contiene un atomo de nitrogeno
PE20030385A1 (es) Compuestos de urea como antagonistas de receptores y5 del neuropeptido y
CY1105253T1 (el) Ετepοπολυκυκλικες ενωσεις και η χρησιμοποιηση τους ως ανταγωνιστες μεταβολοτροπου γλουταμινικου υποδοχεως
EA200301215A1 (ru) Лиганды рецепторов 5-ht и их применение
EA200100822A1 (ru) Baff, относящиеся к нему блокирующие агенты и их применение в стимуляции и ингибировании b-клеток и иммуноглобулинов в иммунных реакциях
PE20011258A1 (es) Derivados de benzocicloalquilenilamina como antagonistas de receptores muscarinicos
PE20021094A1 (es) Derivados de ciclohexano-1,4-diamina sustituidos
PE20010647A1 (es) Moduladores de receptores de retinoide x (rxr) con perfil farmacologico mejorado
CY1108792T1 (el) Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
DE69820632D1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)-piperazin-derivate
RU2007148217A (ru) Получение производных n-фенил-2-пиримидинамина
DE69508093T2 (de) Substituierte piperidine für die behandlung von allergischen krankheiten
AR057056A1 (es) Proceso para la sintesis de imidazol bencilaminas
PE20021097A1 (es) Inmunoconjugados de anticuerpos cd44 citotoxicos
TR199901710T2 (xx) IL-8 resept�r antagonistleri.
WO2007075688A3 (en) Substituted aniline derivatives useful as histamine h3 antagonists
NO20061978L (no) Imidazopyridinsubstituerte tropanderivater med CCR5-reseptorantagonist aktivitet for behandling av HIV og inflammasjon
NO940927D0 (no) Kondenserte tricykliske nitrogenholdige heterocykler som substans-P-reseptor-antagonister
PE20000564A1 (es) Antagonistas receptores y5 de neuropeptidos
PE20030471A1 (es) Compuesto de imidazopiridin como moduladores del receptor 5-ht4
CY1108378T1 (el) 4-υποκατεστημενα παραγωγα 1-αμινοκυκλοεξανιου για την χρησιμοποιηση σαν προσδεματα υποδοχεα orl1 ή οπιακου υποδοχεα mu
HUP0402580A2 (hu) 5-HT-antagonista tulajdonságú kinolinvegyületek és alkalmazásuk gyógyszerkészítmények előállítására
PE20011030A1 (es) Combinaciones farmaceuticas que comprenden tegaserod y omeprazol

Legal Events

Date Code Title Description
FC Refusal